Company / Interest Expense
OCULAR THERAPEUTIX, INC Interest Expense History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$887.0K
FY2024
5-year range
$887.0K / $11.3M
FY2020-FY2024
Trend
-92.2%
vs FY2023
Sector context
#37 of 44
Health Care
What the data says
OCULAR THERAPEUTIX, INC's interest expense of $887,000 is lower than 84% of companies in the Health Care sector (FY2024). Interest Expense has fluctuated over the past 9 years, ranging from $887,000 in FY2024 to $11M in FY2023.
Based on SEC 10-K filings.
$887,000 in FY2024 with a 5-year CAGR of -14.1%.
Improved from $7M to $887,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -47.4%
- 5-Year CAGR
- -14.1%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $887.0K Sector average $291.0M
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -14.1%, indicating a declining trend.
- In FY2024, interest expense decreased 92.2% year-over-year.
- Ranks #37 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $887.0K | -92.2% |
| FY2023 | $11.3M | +67.5% |
| FY2022 | $6.8M | +10.9% |
| FY2021 | $6.1M | +0.0% |
| FY2020 | $6.1M | +222.5% |
| FY2019 | $1.9M | +8.8% |
| FY2018 | $1.7M | -8.1% |
| FY2017 | $1.9M | +12.6% |
| FY2016 | $1.7M | +281.0% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026